Natelle One (Azur Pharma, Inc.)
Welcome to the PulseAid listing for the Natelle One drug offered from Azur Pharma, Inc.. This Calcium [Chemical/Ingredient],Calcium [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Azur Pharma, Inc. |
NON-PROPRIETARY NAME: | Natelle One |
SUBSTANCE NAME: | DOCONEXENT; ICOSAPENT; TRICALCIUM PHOSPHATE; FERROUS FUMARATE; ASCORBIC ACID; PYRIDOXINE HYDROCHLORIDE; ALPHA-TOCOPHEROL, D-; FOLIC ACID |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Calcium [Chemical/Ingredient],Calcium [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, GELATIN COATED |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2009-11-09 |
END MARKETING DATE: | 0000-00-00 |
Natelle One HUMAN PRESCRIPTION DRUG Details:
Item Description | Natelle One from Azur Pharma, Inc. |
LABELER NAME: | Azur Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250; .625; 100; 27; 30; 25; 30; 1(mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; [iU]/1; mg/1) |
START MARKETING DATE: | 2009-11-09 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 18860-852_06b963be-0817-469e-ad3a-8096324fbe94 |
PRODUCT NDC: | 18860-852 |
APPLICATION NUMBER: | na |
Other DOCONEXENT; ICOSAPENT; TRICALCIUM PHOSPHATE; FERROUS FUMARATE; ASCORBIC ACID; PYRIDOXINE HYDROCHLORIDE; ALPHA-TOCOPHEROL, D-; FOLIC ACID Pharmaceutical Manufacturers / Labelers: